SomaLogic, Inc.

SLGC | $2.1 -4.76% 34M

(0.0% 1d) (-2.2% 1m) (-24.7% 1y) (-2.2% 2d) (-4.4% 3d) (0.0% 7d) (NaN% volume)
Earnings Calendar: 2023-11-14
Market Cap: $ 396,226,179
https://somalogic.com
Sec Filling | Patents | 320 employees

(US) SomaLogic, Inc. operates as a healthcare company. The Company offers protein biomarker discovery and clinical diagnostics solutions. SomaLogic serves patients and healthcare professionals worldwide.

diagnostics msa

add to watch list Paper trade email alert is off

Press-releases

Standard BioTools Announces Exchange of All Outstanding Series B Convertible Preferred Stock for Common Stock
Published: 2024-03-18 (Crawled : 12:00) - globenewswire.com
LAB | $2.53 -3.07% -3.16% 2.8M

Manufacturing

| -0.38% | O: -0.38% H: 2.3% C: -0.77%
series

Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2023 Revenue
Published: 2024-01-08 (Crawled : 14:00) - globenewswire.com
LAB | $2.53 -3.07% -3.16% 2.8M

Manufacturing

| 39.57% | O: 0.0% H: 16.84% C: 13.37%
year revenue

Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2023 RevenueAchieving scale with pro forma full year 2023 revenue of approximately $192 million
Published: 2024-01-08 (Crawled : 18:00) - biospace.com/
LAB | $2.53 -3.07% -3.16% 2.8M

Manufacturing

| 39.57% | O: 0.0% H: 16.84% C: 13.37%
pro year million revenue

Standard BioTools Stockholders Approve Merger with SomaLogic
Published: 2024-01-05 (Crawled : 04:00) - globenewswire.com
LAB | $2.53 -3.07% -3.16% 2.8M

Manufacturing

| 35.23% | O: 3.63% H: 1.75% C: -6.5%
SLGC | $2.1 -4.76% 34M

| -2.23% | O: -2.23% H: 0.0% C: 0.0%

SomaLogic Stockholders Vote to Approve Standard BioTools Transaction at Special Meeting
Published: 2024-01-05 (Crawled : 03:00) - prnewswire.com
LAB | $2.53 -3.07% -3.16% 2.8M

Manufacturing

| 35.23% | O: 3.63% H: 1.75% C: -6.5%
SLGC | $2.1 -4.76% 34M

| -2.23% | O: -2.23% H: 0.0% C: 0.0%
meeting

Leading Independent Proxy Advisory Firms Glass Lewis and ISS Both Recommend SomaLogic Stockholders Vote "FOR" Proposed Merger with Standard BioTools
Published: 2023-12-29 (Crawled : 22:00) - prnewswire.com
SLGC | $2.1 -4.76% 34M

| Email alert Add to watchlist
glass

SomaLogic Board Reiterates Value-Maximizing Transaction with Standard BioTools is in Best Interests of All Stockholders
Published: 2023-12-29 (Crawled : 14:00) - prnewswire.com
SLGC | $2.1 -4.76% 34M

| -17.67% | O: 0.56% H: 0.0% C: 0.0%

Dr. Larry Gold and Dr. Jason Cleveland Issue Open Letter to SomaLogic Stockholders Opposing SomaLogic's Proposed Merger with Standard BioTools
Published: 2023-12-28 (Crawled : 22:00) - prnewswire.com
LAB | $2.53 -3.07% -3.16% 2.8M

Manufacturing

| 12.5% | O: -0.86% H: 1.74% C: -3.91%
SLGC | $2.1 -4.76% 34M

| -17.67% | O: 0.56% H: 0.0% C: 0.0%
TMO | News | $541.52 -1.05% 0.61% 2.1M

Health Technology

| 0.27% | O: -0.09% H: 0.0% C: 0.0%

SomaLogic Issues Statement Correcting Madryn Asset Management's Misleading Disclosure
Published: 2023-12-26 (Crawled : 21:00) - prnewswire.com
LAB | $2.53 -3.07% -3.16% 2.8M

Manufacturing

| 21.96% | O: -1.87% H: 5.71% C: 4.76%
LH M | $199.45 -0.26% 0.27% 770K

Health Services

| -11.26% | O: -0.16% H: 0.79% C: 0.74%

ISS Recommends SomaLogic Stockholders Vote “FOR” Proposed Merger with Standard BioTools
Published: 2023-12-22 (Crawled : 00:20) - globenewswire.com
SLGC | $2.1 -4.76% 34M

| Email alert Add to watchlist

See all

Last 15 days Sec forms

File Id	Form	Published Date	Transaction Date	Direction	Code	Amount Transacted	Owned Amount
0001209191-24-001334	4	2024-01-10	2024-01-05	Sell	D	13875	0
0001209191-24-001334	4	2024-01-10	2024-01-05	Sell	D	185812	0
0001209191-24-001334	4	2024-01-10	2024-01-05	Sell	D	48425	0
0001209191-24-001332	4	2024-01-10	2024-01-05	Sell	D	3400	0
0001209191-24-001332	4	2024-01-10	2024-01-05	Sell	D	185400	0